Access cutting-edge obesity treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access obesity specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obesity treatment provided free
The purpose of this trial is to evaluate the efficacy and safety of GV101 for weight loss over a range of doses in participants with obesity. The primary efficacy endpoint is the mean percent change in body weight from baseline at Week 16 in each treated group as compared with placebo.
Sponsor: Graviton Bioscience Corporation
Check if you qualify for this obesity clinical trial in Kansas City, MO
If you're searching for obesity treatment options in Kansas City, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.